The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Oncology Injection Drug Revenue 1.4 Market Analysis by Type 1.4.1 Global Oncology Injection Drug Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Organs 1.4.3 Central Nervous System 1.4.4 Circulatory/Musculoskeletal System 1.5 Market by Application 1.5.1 Global Oncology Injection Drug Market Share by Application: 2021-2026 1.5.2 Lymphoma 1.5.3 Myeloma 1.5.4 Prostate Cancer 1.6 Study Objectives 1.7 Years Considered 1.8 Overview of Global Oncology Injection Drug Market 1.8.1 Global Oncology Injection Drug Market Status and Outlook (2015-2026) 1.8.2 North America 1.8.3 East Asia 1.8.4 Europe 1.8.5 South Asia 1.8.6 Southeast Asia 1.8.7 Middle East 1.8.8 Africa 1.8.9 Oceania 1.8.10 South America 1.8.11 Rest of the World 2 Market Competition by Manufacturers 2.1 Global Oncology Injection Drug Production Capacity Market Share by Manufacturers (2015-2020) 2.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2015-2020) 2.3 Global Oncology Injection Drug Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Oncology Injection Drug Production Sites, Area Served, Product Type 3 Sales by Region 3.1 Global Oncology Injection Drug Sales Volume Market Share by Region (2015-2020) 3.2 Global Oncology Injection Drug Sales Revenue Market Share by Region (2015-2020) 3.3 North America Oncology Injection Drug Sales Volume 3.3.1 North America Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.3.2 North America Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 East Asia Oncology Injection Drug Sales Volume 3.4.1 East Asia Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.4.2 East Asia Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Europe Oncology Injection Drug Sales Volume (2015-2020) 3.5.1 Europe Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.5.2 Europe Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 South Asia Oncology Injection Drug Sales Volume (2015-2020) 3.6.1 South Asia Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.6.2 South Asia Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Southeast Asia Oncology Injection Drug Sales Volume (2015-2020) 3.7.1 Southeast Asia Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.7.2 Southeast Asia Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Middle East Oncology Injection Drug Sales Volume (2015-2020) 3.8.1 Middle East Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.8.2 Middle East Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Africa Oncology Injection Drug Sales Volume (2015-2020) 3.9.1 Africa Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.9.2 Africa Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Oceania Oncology Injection Drug Sales Volume (2015-2020) 3.10.1 Oceania Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.10.2 Oceania Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 South America Oncology Injection Drug Sales Volume (2015-2020) 3.11.1 South America Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.11.2 South America Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Rest of the World Oncology Injection Drug Sales Volume (2015-2020) 3.12.1 Rest of the World Oncology Injection Drug Sales Volume Growth Rate (2015-2020) 3.12.2 Rest of the World Oncology Injection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020) 4 North America 4.1 North America Oncology Injection Drug Consumption by Countries 4.2 United States 4.3 Canada 4.4 Mexico 5 East Asia 5.1 East Asia Oncology Injection Drug Consumption by Countries 5.2 China 5.3 Japan 5.4 South Korea 6 Europe 6.1 Europe Oncology Injection Drug Consumption by Countries 6.2 Germany 6.3 United Kingdom 6.4 France 6.5 Italy 6.6 Russia 6.7 Spain 6.8 Netherlands 6.9 Switzerland 6.10 Poland 7 South Asia 7.1 South Asia Oncology Injection Drug Consumption by Countries 7.2 India 7.3 Pakistan 7.4 Bangladesh 8 Southeast Asia 8.1 Southeast Asia Oncology Injection Drug Consumption by Countries 8.2 Indonesia 8.3 Thailand 8.4 Singapore 8.5 Malaysia 8.6 Philippines 8.7 Vietnam 8.8 Myanmar 9 Middle East 9.1 Middle East Oncology Injection Drug Consumption by Countries 9.2 Turkey 9.3 Saudi Arabia 9.4 Iran 9.5 United Arab Emirates 9.6 Israel 9.7 Iraq 9.8 Qatar 9.9 Kuwait 9.10 Oman 10 Africa 10.1 Africa Oncology Injection Drug Consumption by Countries 10.2 Nigeria 10.3 South Africa 10.4 Egypt 10.5 Algeria 10.6 Morocco 11 Oceania 11.1 Oceania Oncology Injection Drug Consumption by Countries 11.2 Australia 11.3 New Zealand 12 South America 12.1 South America Oncology Injection Drug Consumption by Countries 12.2 Brazil 12.3 Argentina 12.4 Columbia 12.5 Chile 12.6 Venezuela 12.7 Peru 12.8 Puerto Rico 12.9 Ecuador 13 Rest of the World 13.1 Rest of the World Oncology Injection Drug Consumption by Countries 13.2 Kazakhstan 14 Sales Volume, Sales Revenue, Sales Price Trend by Type 14.1 Global Oncology Injection Drug Sales Volume Market Share by Type (2015-2020) 14.2 Global Oncology Injection Drug Sales Revenue Market Share by Type (2015-2020) 14.3 Global Oncology Injection Drug Sales Price by Type (2015-2020) 15 Consumption Analysis by Application 15.1 Global Oncology Injection Drug Consumption Volume by Application (2015-2020) 15.2 Global Oncology Injection Drug Consumption Value by Application (2015-2020) 16 Company Profiles and Key Figures in Oncology Injection Drug Business 16.1 Taj Oncology 16.1.1 Taj Oncology Company Profile 16.1.2 Taj Oncology Oncology Injection Drug Product Specification 16.1.3 Taj Oncology Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.2 Genzyme 16.2.1 Genzyme Company Profile 16.2.2 Genzyme Oncology Injection Drug Product Specification 16.2.3 Genzyme Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.3 Merrimack 16.3.1 Merrimack Company Profile 16.3.2 Merrimack Oncology Injection Drug Product Specification 16.3.3 Merrimack Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.4 S.G. Biopharm 16.4.1 S.G. Biopharm Company Profile 16.4.2 S.G. Biopharm Oncology Injection Drug Product Specification 16.4.3 S.G. Biopharm Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.5 Ferring Pharmaceuticals 16.5.1 Ferring Pharmaceuticals Company Profile 16.5.2 Ferring Pharmaceuticals Oncology Injection Drug Product Specification 16.5.3 Ferring Pharmaceuticals Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.6 AdvaCare 16.6.1 AdvaCare Company Profile 16.6.2 AdvaCare Oncology Injection Drug Product Specification 16.6.3 AdvaCare Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.7 Praecis Pharmaceuticals 16.7.1 Praecis Pharmaceuticals Company Profile 16.7.2 Praecis Pharmaceuticals Oncology Injection Drug Product Specification 16.7.3 Praecis Pharmaceuticals Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.8 Allos Therapeutics 16.8.1 Allos Therapeutics Company Profile 16.8.2 Allos Therapeutics Oncology Injection Drug Product Specification 16.8.3 Allos Therapeutics Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.9 Celgene 16.9.1 Celgene Company Profile 16.9.2 Celgene Oncology Injection Drug Product Specification 16.9.3 Celgene Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.10 Eli Lilly 16.10.1 Eli Lilly Company Profile 16.10.2 Eli Lilly Oncology Injection Drug Product Specification 16.10.3 Eli Lilly Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.11 Pharmascience 16.11.1 Pharmascience Company Profile 16.11.2 Pharmascience Oncology Injection Drug Product Specification 16.11.3 Pharmascience Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.12 Millennium Pharmaceuticals 16.12.1 Millennium Pharmaceuticals Company Profile 16.12.2 Millennium Pharmaceuticals Oncology Injection Drug Product Specification 16.12.3 Millennium Pharmaceuticals Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.13 CordenPharma 16.13.1 CordenPharma Company Profile 16.13.2 CordenPharma Oncology Injection Drug Product Specification 16.13.3 CordenPharma Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.14 Debiopharm 16.14.1 Debiopharm Company Profile 16.14.2 Debiopharm Oncology Injection Drug Product Specification 16.14.3 Debiopharm Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 16.15 Alza 16.15.1 Alza Company Profile 16.15.2 Alza Oncology Injection Drug Product Specification 16.15.3 Alza Oncology Injection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 17 Oncology Injection Drug Manufacturing Cost Analysis 17.1 Oncology Injection Drug Key Raw Materials Analysis 17.1.1 Key Raw Materials 17.2 Proportion of Manufacturing Cost Structure 17.3 Manufacturing Process Analysis of Oncology Injection Drug 17.4 Oncology Injection Drug Industrial Chain Analysis 18 Marketing Channel, Distributors and Customers 18.1 Marketing Channel 18.2 Oncology Injection Drug Distributors List 18.3 Oncology Injection Drug Customers 19 Market Dynamics 19.1 Market Trends 19.2 Opportunities and Drivers 19.3 Challenges 19.4 Porter's Five Forces Analysis 20 Production and Supply Forecast 20.1 Global Forecasted Production of Oncology Injection Drug (2021-2026) 20.2 Global Forecasted Revenue of Oncology Injection Drug (2021-2026) 20.3 Global Forecasted Price of Oncology Injection Drug (2015-2026) 20.4 Global Forecasted Production of Oncology Injection Drug by Region (2021-2026) 20.4.1 North America Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.2 East Asia Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.3 Europe Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.4 South Asia Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.5 Southeast Asia Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.6 Middle East Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.7 Africa Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.8 Oceania Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.9 South America Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.4.10 Rest of the World Oncology Injection Drug Production, Revenue Forecast (2021-2026) 20.5 Forecast by Type and by Application (2021-2026) 20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 20.5.2 Global Forecasted Consumption of Oncology Injection Drug by Application (2021-2026) 21 Consumption and Demand Forecast 21.1 North America Forecasted Consumption of Oncology Injection Drug by Country 21.2 East Asia Market Forecasted Consumption of Oncology Injection Drug by Country 21.3 Europe Market Forecasted Consumption of Oncology Injection Drug by Countriy 21.4 South Asia Forecasted Consumption of Oncology Injection Drug by Country 21.5 Southeast Asia Forecasted Consumption of Oncology Injection Drug by Country 21.6 Middle East Forecasted Consumption of Oncology Injection Drug by Country 21.7 Africa Forecasted Consumption of Oncology Injection Drug by Country 21.8 Oceania Forecasted Consumption of Oncology Injection Drug by Country 21.9 South America Forecasted Consumption of Oncology Injection Drug by Country 21.10 Rest of the world Forecasted Consumption of Oncology Injection Drug by Country 22 Research Findings and Conclusion 23 Methodology and Data Source 23.1 Methodology/Research Approach 23.1.1 Research Programs/Design 23.1.2 Market Size Estimation 23.1.3 Market Breakdown and Data Triangulation 23.2 Data Source 23.2.1 Secondary Sources 23.2.2 Primary Sources 23.3 Disclaimer
Price : US$ 3,500 | Date : Mar 2024 |
Category : Chemicals and Materials | Pages : 123 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 139 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 200 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 254 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 250 |
We will be happy to help you find what you need. Please call us or write to us: